Código QR (código de barras bidimensional)

Long Term Metabolic Effects of Sacubitril/Valsartan in Non-Diabetic and Diabetic Patients With Heart Failure Reduced Ejection Fraction: A Real Life Study

Sacubitril/Valsartan (sac/val) has improved clinical prognosis in patients affected by heart failure (HF) with reduced ejection fraction (HFrEF). HF and type 2 diabetes mellitus (T2DM) frequently coexist, with a prevalence of T2DM of 35%–40% in patients with HF. T2DM is the third co-morbidities in p...

ver descrição completa

Na minha lista:
Principais autores: Giuseppe Armentaro, Graziella D’Arrigo, Sofia Miceli, Velia Cassano, Maria Perticone, Raffaele Maio, Alberto Maria Marra, Franco Arturi, Antonio Cittadini, Giovanni Tripepi, Giorgio Sesti, Angela Sciacqua
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2022-05-01
coleção:Frontiers in Physiology
Assuntos:
sacubitril/valsartan
type 2 diabetes mellitus
HbA1c
cardiac index
global longitudinal strain
heart failure with reduced ejection fraction
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fphys.2022.897109/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados